Neonatal opiate withdrawal and rooming-in: A retrospective analysis of a single center experience

Klinische Padiatrie

Volumn 225, Issue 5, 2013, Pages 247-251

  Hunseler C ^a   Bruckle M ^a   Roth, B ^a   Kribs, A ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Entzug; Methadon; Neonatales Abstinenz Syndrom; Neugeborenes; Opiate; Rooming in

Indexed keywords

ALCOHOL; BENZODIAZEPINE DERIVATIVE; COCAINE; DIAMORPHINE; METHADONE; MORPHINE; NICOTINE; NITRAZEPAM; OPIATE; OPIATE DERIVATIVE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST CONTROL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; GERMANY; HEALTH CARE COST; HUMAN; INFANT; LENGTH OF STAY; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; NEWBORN; PEDIATRIC HOSPITAL; PRENATAL DRUG EXPOSURE; RETROSPECTIVE STUDY; ROOMING IN; SINGLE DRUG DOSE; TINCTURE; TREATMENT DURATION; URBAN AREA; WITHDRAWAL SYNDROME;

ADULT; COHORT STUDIES; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GERMANY; HOSPITALS, UNIVERSITY; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; MALE; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; OPIUM; PERINATAL CARE; RETROSPECTIVE STUDIES; ROOMING-IN CARE; TREATMENT OUTCOME;

EID: 84883861445     PISSN: 03008630     EISSN: 14393824     Source Type: Journal    
DOI: 10.1055/s-0033-1347190     Document Type: Article

References (33)

1. Abrahams R. R., Kelly S. A., Payne S. et al. Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Can Fam Physician: 2007; 53 1722 1730 (Pubitemid 351194540)
2. Agthe A. G., Kim G. R., Mathias K. B. et al. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics: 2009; 123 849 856
3. Almario C. V., Seligman N. S., Dysart K. C. et al. Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program. Am J Obstet Gynecol: 2009; 326 1 6
4. American Academy of Pediatrics Committee on Drugs Neonatal drug withdrawal. Pediatrics: 1998; 101 1079 1088
5. Autret F., Mucignat V., De Montgolfier-Aubron I. et al. Use of diazepam in the treatment of opioid neonatal abstinence syndrome. Arch Pediatr: 2004; 11 1308 1313 (Pubitemid 39446404)
6. Bandstra E. S., Morrow C. E., Mansoor E. et al. Prenatal drug exposure: infant and toddler outcomes. J Addict Dis: 2010; 29 245 258
7. Bläser A., Pulzer F., Knüpfer M. et al. Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done? Klin Padiatr: 2008; 220 308 315
8. Cleary B. J., Donnelly J. M., Strawbridge J. D. et al. Methadone and perinatal outcomes: a retrospective cohort study. Am J Obstet Gynecol: 2011; 139 e1 e9
9. Cleary B. J., Donnelly J., Strawbridge J. et al. Methadone dose and neonatal abstinence syndrome - systematic review and meta-analysis. Addiction: 2010; 105 2071 2084
10. Coyle M. G., Ferguson A., Lagasse L. et al. Diluted tincture of opium (DTO) and phenobarbitone versus DTO alone for neonatal opiate withdrawal in term infants. J Pediatr: 2002; 140 561 564 (Pubitemid 34666726)
11. Doberczak T. M., Kandall S. R., Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr: 1991; 118 933 937
12. Dysart K., Hsieh H. C., Kaltenbach K. et al. Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome. J Perinat Med: 2007; 35 344 346 (Pubitemid 47036964)
13. Finnegan L. P., Connaughton J. F., Kron R. E. et al. Neonatal abstinence syndrome: assessment and management. Addict Dis: 1975; 2 141 158
14. Goel N., Beasley D., Rajkumar V. et al. Perinatal outcome of illicit substance use in pregnancy - comparative and contemporary socio-clinical profile in the UK. Eur J Pediatr: 2011; 170 199 205
15. Heimann K., Bartz C., Silvestri A. et al. Methadone Substitution during Pregnancy: Relationship between Dose and Effect in Neonatal Abstinence Syndrome. Geburtsh Frauenheilk: 2006; 66 277 283
16. Hüning B. M., Reimann M., Beerenberg U. et al. Establishment of a family-centred care programme with follow-up home visits: implications for clinical care and economic characteristics. Klin Padiatr: 2012; 224 431 436
17. Johnson K., Gerada C., Greenough A. Treatment of neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed: 2003; 88 F2 F5 (Pubitemid 36084199)
18. Kaltenbach K., Finnegan L. P. Neonatal abstinence syndrome, pharmacotherapy and developmental outcome. Neurobehav Toxicol Teratol: 1986; 8 353 355 (Pubitemid 16049639)
19. Kraft W. K., van den Anker J. N. Pharmacologic management of the opioid neonatal abstinence syndrome. Pediatr Clin North Am: 2012; 59 1147 1165
20. Kraft W. K., Dysart K., Greenspan J. S. et al. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction: 2011; 106 574 580
21. Lam S. K., To W. K., Duthie S. J. et al. Narcotic addiction in pregnancy with adverse maternal and perinatal outcome. Aust N Z J Obstet Gynaecol: 1992; 32 216 221
22. Langenfeld S., Birkenfeld L., Herkenrath P. et al. Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops. Drug Alcohol Depend: 2005; 77 31 36 (Pubitemid 39656097)
23. Lejeune C., Simmat-Durand L., Gourarier L. et al. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution. Drug Alcohol Depend: 2006; 82 250 257
24. Lim S., Prasad M. R., Samuels P. et al. High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome. Am J Obstet Gynecol: 2009; 200 70 e1 70 e5
25. Loepke A. W. Developmental neurotoxicity of sedatives and anesthetics: a concern for neonatal and pediatric critical care medicine? Pediatr Crit Care Med: 2010; 11 217 226
26. McLemore G. L., Lewis T., Jones C. H. et al. Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome. Semin Fetal Neonatal Med: 2013; 18 35 41
27. Müller M. J., Lange M., Paul T. et al. Breast feeding during methadon- and buprenorphin therapy. Klin Padiatr: 2011; 223 408 413
28. Osborn D. A., Jeffery H. E., Cole M. J. Sedatives for opiate withdrawal in newborn infants. Cochrane Database Syst Rev: 2010; CD002053
29. Osborn D. A., Jeffery H. E., Cole M. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev: 2005; CD002059
30. Rohrmeister K., Bernert G., Langer M. et al. Opiate addiction in gravidity - consequences for the newborn. Results of an interdisciplinary treatment concept. Z Geburtshilfe Neonatol: 2001; 205 224 230 (Pubitemid 33151420)
31. Saiki T., Lee S., Hannam S. et al. Neonatal abstinence syndrome - postnatal ward versus neonatal unit management. Eur J Pediatr: 2010; 169 95 98
32. Sarkar S., Donn S. M. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol: 2006; 26 15 17 (Pubitemid 43135249)
33. Seligman N. S., Almario C. V., Hayes E. J. et al. Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome. J Pediatr: 2010; 157 428 433